ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,264Medicare Part D Prescriptions Filled, Including Refills

Rank: 163 out of 780

$719K Total Retail Price of All Prescriptions

Rank: 156 out of 780

524 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 7,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 1,089 619 1 4
PRAVASTATIN SODIUM 706 384 2 9
ATORVASTATIN CALCIUM 493 348 3 12
CLONIDINE HCL 455 230 4 28
FUROSEMIDE 429 244 5 7
GLIMEPIRIDE 396 232 6 30
CARVEDILOL 395 181 7 14
KLOR-CON 8 327 167 8 194
LISINOPRIL 305 161 9 6
HYDROCODONE-ACETAMINOPHEN 301 63 S3 10 1
LOSARTAN POTASSIUM 246 140 11 18
LEVOTHYROXINE SODIUM 243 145 12 5
METFORMIN HCL 242 111 13 8
OMEPRAZOLE 238 136 14 3
ZETIA 215 138 15 94
HYDROCHLOROTHIAZIDE 202 115 16 10
POTASSIUM CHLORIDE 191 119 17 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 191 87 17 26
QUINAPRIL HCL 184 82 19 113
METFORMIN HCL ER 182 119 20 43
METOPROLOL TARTRATE 174 108 21 19
CLOPIDOGREL 163 102 22 34
ATENOLOL 163 95 22 21
SIMVASTATIN 159 142 24 2
RAMIPRIL 151 78 25 70
DIOVAN 150 79 26 55
NASONEX 141 66 27 254
LYRICA 138 53 28 52
HYDRALAZINE HCL 126 70 29 54
GABAPENTIN 126 60 29 13
PROAIR HFA 125 33 31 62
HYDROXYZINE HCL 123 51 R 32 155
AMLODIPINE BESYLATE-BENAZEPRIL 113 73 33 50
ALLOPURINOL 111 41 34 29
FAMOTIDINE 108 35 35 86
LOVASTATIN 107 29 36 47
PLAVIX 105 73 37 45
JANUVIA 102 74 38 85
NOVOLOG MIX 70-30 FLEXPEN 94 57 39 222
METOPROLOL SUCCINATE 93 77 40 20
HUMALOG MIX 75-25 92 52 41 243
NEXIUM 90 41 42 22
PEN NEEDLE 88 46 43 136
ESCITALOPRAM OXALATE 82 39 44 61
EXFORGE 82 28 44 196
ISOSORBIDE MONONITRATE ER 79 57 46 60
TRIAMTERENE-HCTZ 75 27 47 37
INSULIN SYRINGE 71 46 48 80
IBUPROFEN 71 22 48 93
ALENDRONATE SODIUM 71 66 48 44
SPIRIVA 68 30 51 72
KLOR-CON 10 67 50 52 90
LOSARTAN-HYDROCHLOROTHIAZIDE 66 28 53 33
NAPROXEN 65 41 54 100
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 36 55 188
DILTIAZEM ER 62 46 56 134
CYCLOBENZAPRINE HCL 61 17 R 57 42
SPIRONOLACTONE 61 28 57 53
ACETAMINOPHEN-CODEINE 60 18 S3 59 116
VERAPAMIL ER 59 56 60 78
BENAZEPRIL HCL 56 35 61 59
WARFARIN SODIUM 55 20 62 24
GLIPIZIDE 54 28 63 74
PANTOPRAZOLE SODIUM 53 41 64 25
PHENYTOIN SODIUM EXTENDED 52 21 65 128
NAMENDA 51 17 66 46
NOVOLIN 70-30 50 28 67 164
CRESTOR 50 29 67 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.